tiprankstipranks
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO

BridgeBio Pharma (BBIO) Ownership - Who Owns BridgeBio Pharma?

794 Followers

BridgeBio Pharma (BBIO) Ownership Overview

50.37%15.80%12.92%20.90%
50.37% Insiders
12.92% Other Institutional Investors
20.90% Public Companies and Individual Investors
The ownership structure of BridgeBio Pharma (BBIO) stock is a mix of institutional, retail and individual investors. Approximately 28.73% of the company’s stock is owned by Institutional Investors, 50.37% is owned by Insiders and 20.90% is owned by Public Companies and Individual Investors.
The ownership structure of BridgeBio Pharma (BBIO) stock is a mix of institutional, retail and individual investors. Approximately 28.73% of the company’s stock is owned by Institutional Investors, 50.37% is owned by Insiders and 20.90% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 13, 2024Bought$44476
Jul 19, 2023Sold$52500000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$43559
Dec 31, 2023Bought$242220
Dec 31, 2023Bought$342579
Dec 31, 2023Sold$1619725

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
25,120,991Institution13.62%639,580,431
12,713,607Institution6.89%323,688,434
11,360,169Institution6.16%289,229,903
6,068,125Institution3.29%154,494,463
5,505,844Institution2.98%140,178,788
2,755,631Institution1.49%70,158,365
1,748,933Institution0.95%44,527,834
1,451,626Institution0.79%36,958,398
1,319,468Institution0.72%33,593,655
1,291,962Institution0.70%32,893,353

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
11,360,169Institution6.16%289,229,903
1,451,626Institution0.79%36,958,398
1,319,468Institution0.72%33,593,655
1,291,962Institution0.70%32,893,353
1,135,537Institution0.62%28,910,772
965,653Institution0.52%24,585,525
946,496Institution0.51%24,097,788
788,441Institution0.43%20,073,708
664,442Institution0.36%16,916,693
655,400Institution0.36%16,686,484

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,356,743Institution2.36%134,710,494
3,528,728Institution1.91%109,108,270
2,752,402Institution1.49%70,076,155
2,590,715Institution1.40%65,959,604
1,931,252Institution1.05%59,714,312
998,874Institution0.54%30,885,184
890,087Institution0.48%27,521,490
971,639Institution0.53%24,737,929
690,034Institution0.37%17,568,266
609,043Institution0.33%15,506,235

FAQ

Who Owns BridgeBio Pharma Inc (BBIO)?
According to the latest TipRanks data, approximately 12.92% of the company's stock is held by institutional investors, 50.37% is held by insiders, and 20.90% is held by retail investors.
    What percentage of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 12.92% of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors.
      What percentage of BridgeBio Pharma Inc (BBIO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 20.90% of BridgeBio Pharma Inc (BBIO) stock is held by retail investors.
        Who owns the most shares of BridgeBio Pharma Inc (BBIO)?
        Andreas Halvorsen owns the most shares of BridgeBio Pharma Inc (BBIO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis